The Blood Grouping Reagents Market in Belgium experienced fluctuating trends between 2012 and 2022. Initially, the market value declined until 2015, followed by a period of recovery and growth peaking in 2018, only to face a drop again in subsequent years. Notably, the CAGR over the last five years stands at -2.02%, indicating a slight downward trend on average per year.
Future trends to watch for include potential technological advancements in reagent formulations, shifts in healthcare protocols, and possible regulatory changes affecting market dynamics. Market stakeholders should keep a close eye on innovations in diagnostic technologies and changes in blood testing procedures.
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 10 | 10 Hungary | 8,505,100 | 2023 | +0.8% | -2.77% | View data |
| 11 | 11 Portugal | 8,140,900 | 2023 | -11.08% | -6.98% | View data |
| 12 | 12 Belgium | 7,578,800 | 2023 | -0.5% | -2.57% | |
| 13 | 13 Croatia | 4,027,100 | 2023 | -3.49% | -1.48% | View data |
| 14 | 14 Denmark | 3,569,200 | 2023 | -2.29% | -3.12% | View data |
